Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Biodegradation of the fluorinated non-steroidal anti-inflammatory pharmaceutical Flurbiprofen by environmental bacterial isolates
Date
2015-12-31
Author
Murdoch, Robert Waller
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
228
views
0
downloads
Cite This
Flurbiprofen is a fluorinated non-steroidal anti-inflammatory pharmaceutical. While flurbiprofen is quite popular in Turkey, there is at the present time no information as to how environmental bacteria degrade this chemical. Organisms capable of using flurbiprofen as sole carbon and energy source will be enriched from Ankara municipal sewage treatment plant. Strains will be isolated and identified using molecular methods. The general features of degradation pathways employed by unique strains will be characterized by HPLC. The appearance of metabolic byproducts, which is likely given the fluorinated nature of the chemical, will be monitored by HPLC. Toxicity of flurbiprofen culture supernatants will be analyzed by standard bacterial growth inhibition assay. Culture supernatants and individual metabolic products that are detectable and fractionatable by HPLC will be structurally characterized by GC/MS and/or NMR. Unique pathways will be further characterized by assays upon flurbiprofen-induced resting cell assays; degradation of catechol, phenylacetic acid, and various simple aromatic compounds will be used to gain insight into the pathways employed by these bacteria. The EC50 for bacterial growth inhibition will be calculated for any specific metabolic intermediates that can either be isolated by HPLC fractionation or purchased from chemical distributors. The expected outcome is the isolation and identification of the first flurbiprofen degrading organisms to be desc
Subject Keywords
Çevre Kirliliği
,
Bakteriyoloji
,
Mikrobiyal Çeşitlilik
URI
https://hdl.handle.net/11511/61942
Collections
Department of Environmental Engineering, Project and Design
Suggestions
OpenMETU
Core
Biotransformation of the Fluorinated Nonsteroidal Anti-Inflammatory Pharmaceutical Flurbiprofen in Activated Sludge Results in Accumulation of a Recalcitrant Fluorinated Aromatic Metabolite
Yanac, Kadir; Murdoch, Robert Waller (2019-06-01)
Flurbiprofen is a fluorinated, nonsteroidal, anti-inflammatory pharmaceutical with potential application in a wide range of maladies. Currently, there is no information regarding its environmental fate. To address this, flurbiprofen is spiked at 500 and 50 ppm into activated sewage sludge taken from the municipal treatment plant of Ankara, Turkey. Flurbiprofen is partially degraded after 80 days, with removal proportion varying from 33% to 48%. Isolation of organisms able to use flurbiprofen as a sole carbo...
Biodegradation of the fluorinated non-steroidal anti-inflammatory pharmaceutical flurbiprofen
Yanaç, Kadir; Murdoch, Robert W.; Kentel Erdoğan, Elçin; Department of Environmental Engineering (2016)
Flurbiprofen (FLB) is a fluorinated aromatic acid non-steroidal anti-inflammatory pharmaceutical which is widely consumed in Turkey. However, nothing is known regarding its environmental fate. The aim of this master thesis study was to contribute to the understanding of the biodegradation of flurbiprofen (FLB) by environmental bacteria and to gain understanding of the biological activities of fluorinated aromatics and their tendencies to result in toxic byproducts. FLB was spiked into aerobic sewage sludge ...
Interaction of the cholesterol reducing agent simvastatin with zwitterionic DPPC and charged DPPG phospholipid membranes
Sariisik, Ediz; KOÇAK, MUSTAFA; Baloglu, Fatma Kucuk; Severcan, Feride (Elsevier BV, 2019-04-01)
Simvastatin is a lipid-lowering drug in the pharmaceutical group statins. Interaction of a drug with lipids may define its role in the system and be critical for its pharmacological activity. We examined the interactions of simvastatin with zwitterionic dipalmitoyl phosphatidylcholine (DPPC) and anionic dipalmitoyl phosphatidylglycerol (DPPG) multilamellar vesicles (MLVs) as a function of temperature at different simvastatin concentrations using Fourier transform infrared (FTIR) spectroscopy and differentia...
Improvement of solubility of celecoxib by inclusion in MCM-41 mesoporous silica: drug loading and release
Gunaydin, Sahika; Yılmaz, Ayşen (2015-01-01)
Celecoxib is a poorly water-soluble nonsteroidal anti-inflammatory drug. Here we report four ordered mesoporous silica MCM-41 supports with different particle size, pore volume, and surface properties to investigate their loading capacity with celecoxib and their release abilities. Spherical MCM-41 mesoporous supports less than 50 nm in diameter were prepared and to compare the effect of the template removal process on morphology of samples, acid extraction and calcination methods were used. Moreover, nearl...
Alteration of protein and gene expressions of Hexokinase II in PC3 cell lines by cisplatinmetformin combination treatment
Durukan, Özlem; Akkulak, Merve; Evin, Emre; Arslan, Şevki; Adalı, Orhan (null; 2018-07-01)
Metformin is an antidiabetic drug with anticancer properties. Cisplatin is known as one of the most potent chemotherapeutics for treatment of various types of cancer. In order to overcome cisplatin resistance and toxicity, the drug can be combined with other drugs that sensitize tumour cells to cisplatin. The ability of metformin to potentiate cisplatin-mediated killing of cancer cells in vitro, makes it a plausible candidate for combination with cisplatin- based therapy. The aim of this study is to examine...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
R. W. Murdoch, “Biodegradation of the fluorinated non-steroidal anti-inflammatory pharmaceutical Flurbiprofen by environmental bacterial isolates,” 2015. Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/61942.